140 related articles for article (PubMed ID: 37734655)
1. Prevalence of atrial septal defects and patent foramen ovale in a cohort of sudden cardiac death patients undergoing autopsy.
Fahy L; Rowe S; Nehme Z; Stub D; Zentner D; James P; Pflaumer A; Connell V; Semsarian C; Ingles J; La Gerche A; Paratz ED
J Cardiol; 2024 Jun; 83(6):390-393. PubMed ID: 37734655
[TBL] [Abstract][Full Text] [Related]
2. Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes.
Delabays C; Correia P; Eeckhout E; Delabays A; Michel P
J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107664. PubMed ID: 38428550
[TBL] [Abstract][Full Text] [Related]
3. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
4. Increased Risk of Perioperative Ischemic Stroke in Patients Who Undergo Noncardiac Surgery with Preexisting Atrial Septal Defect or Patent Foramen Ovale.
Villablanca PA; Lemor A; So CY; Kang G; Jain T; Gupta T; Ando T; Mohananey D; Ranka S; Hernandez-Suarez DF; Michel P; Frisoli T; Wang DD; Eng M; O'Neill W; Ramakrishna H
J Cardiothorac Vasc Anesth; 2020 Aug; 34(8):2060-2068. PubMed ID: 32127264
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
Van de Bruaene A; Stroobants D; Benit E
Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
[TBL] [Abstract][Full Text] [Related]
6. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
7. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
[TBL] [Abstract][Full Text] [Related]
8. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the size of persistent foramen ovale and atrial septal defects in divers with shunt-related decompression illness and in the general population.
Wilmshurst PT; Morrison WL; Walsh KP
Diving Hyperb Med; 2015 Jun; 45(2):89-93. PubMed ID: 26165530
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Closure of a Cribriform Secundum Atrial Septal Defect and Patent Foramen Ovale.
Wilson J; Oberoi M; Stys T; Stys A
S D Med; 2021 May; 74(5):227-229. PubMed ID: 34437781
[TBL] [Abstract][Full Text] [Related]
11. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
12. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
[TBL] [Abstract][Full Text] [Related]
13. Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
Scicchitano P; Gesualdo M; Cortese F; Acquaviva T; de Cillis E; Bortone AS; Ciccone MM
Heart Vessels; 2019 Sep; 34(9):1499-1508. PubMed ID: 30895384
[TBL] [Abstract][Full Text] [Related]
14. Atrial Septal Defect and the Risk of Ischemic Stroke in the Perioperative Period of Noncardiac Surgery.
Smilowitz NR; Subashchandran V; Berger JS
Am J Cardiol; 2019 Oct; 124(7):1120-1124. PubMed ID: 31375244
[TBL] [Abstract][Full Text] [Related]
15. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
17. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
[TBL] [Abstract][Full Text] [Related]
18. Atrial Septal Defect Increases the Risk for Stroke After Total Hip Arthroplasty.
Perfetti DC; Chughtai M; Boylan MR; Naziri Q; Maheshwari AV; Mont MA
J Arthroplasty; 2017 Oct; 32(10):3152-3156. PubMed ID: 28602537
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous treatment of atrial septal defect and patent foramen ovale].
Lempereur M; Lancellotti P
Rev Med Liege; 2019 Sup; 74(S1):S87-S96. PubMed ID: 31070322
[TBL] [Abstract][Full Text] [Related]
20. Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
Skibsted CV; Korsholm K; Pedersen L; Bonnesen K; Nielsen-Kudsk JE; Schmidt M
Eur Heart J; 2023 Sep; 44(36):3469-3477. PubMed ID: 37279491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
